Xero shares (ASX:XRO) closed out September at A$56.92, within touching distance of a decade low, capping a brutal quarter that has left the cloud accounting giant nursing a near-50% year-to-date loss.
Holders of XRO have had little to cheer over the past month, with the words ‘wake me up when September ends’ proving too true for a stock that has fallen back 31.65% on the month. From a technical standpoint, bears are clearly in charge of momentum, with Xero’s 30-day SMA crossed below its 50-day (at A$72.02 and A$72.90 respectively), a bearish signal that typically confirms a shift in near-term trend momentum rather than merely reflecting it.
The RSI has since fallen to 24.79, placing the stock deep in oversold territory, with Xero’s share price having given back 49.29% of its value so far this year. The latest move puts the stock within 70 cents of levels not seen in roughly a decade, opening up Q4 as a potentially pivotal period.
The gap between where Xero is trading and where analysts believe it could be is now substantial. RBC Capital’s price target sits at A$85, whilst Citi is more constructive still, with a target of A$113.60. Discounted cash flow analyses have produced estimated intrinsic values ranging as high as A$133.38, depending on assumptions around terminal growth rates and margin recovery.
That said, the market is clearly demanding a higher margin of safety before stepping back in with the stock continuing to be one of the most expensive on the market with a P/E of 69.49. The combination of a high starting multiple, margin compression from Melio, rising Australian yields, and a deteriorating technical picture has created a feedback loop that has been difficult to interrupt.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
A bearish moving average crossover also tends to attract momentum-driven selling that can persist beyond what fundamentals alone would justify. On the flip side, an RSI reading of 24.79 is the kind of level that has historically precedes technical relief rallies in oversold growth stocks, even if those rallies do not always mark a durable bottom.
The question for longer-term holders is whether the fundamental case of 30% revenue growth, NZ$554 million in free cash flow, a 100-million SMB total addressable market, and management guidance pointing to continued expansion, is sufficient to anchor a recovery once macro conditions stabilise.
Bull Case:
- RSI at 24.79 signals extreme oversold conditions, historically preceding technical relief rallies.
- Broker consensus targets of A$85 to A$113 imply 50% to 100% upside from current levels.
- Free cash flow of NZ$554 million demonstrates strong underlying business cash generation.
- US revenue surged 240% post-Melio, unlocking a 100-million SMB total addressable market.
Bear Case:
- Bearish moving average crossover confirms active near-term selling momentum remains intact.
- Gross margins contracted from 89% to 83.9%, with further Melio dilution possible ahead.
- Trailing P/E above 100 times remains vulnerable to any further RBA rate increases.
- Net profit fell 27% year-on-year, raising questions about near-term earnings recovery pace.
